logo
Million-Dollar Project Aims to Expose Bad Medical Research

Million-Dollar Project Aims to Expose Bad Medical Research

Gizmodo07-06-2025
Armed with funding, algorithms, and a tip line, this new effort aims to dig corrupt studies out of medical literature before they do real-world harm.
A new initiative from the watchdogs behind Retraction Watch is taking aim at flawed or faked medical science research to the tune of nearly $1 million.
The Center for Scientific Integrity just launched the Medical Evidence Project, a two-year effort to identify published medical research with a negative effect on health guidelines—and to make sure people actually hear about it.
Equipped with a $900,000 grant from Open Philanthropy and a core team of up to five investigators, the project will use forensic metascience tools to identify issues in scientific articles, and report its findings via Retraction Watch, the foremost site for scientific watchdogging.
'We originally set up the Center for Scientific Integrity as a home for Retraction Watch, but we always hoped we would be able to do more in the research accountability space,' said Ivan Oransky, executive director of the Center and co-founder of Retraction Watch, in a post announcing the grant. 'The Medical Evidence Project allows us to support critical analysis and disseminate the findings.'
According to Nature, these flawed and falsified documents are vexing because they skew meta-analyses—reviews that combine the findings from multiple studies to draw more statistically robust conclusions. If one or two bunk studies make it into a meta-analysis, they can tip the scales on health policy.
In 2009, to name one case, a European guideline recommended the use of beta-blockers during non-cardiac surgery, based on turn-of-the-millennium research that was later called into question. Years later, an independent review suggested that the guidance may have contributed to 10,000 deaths per year in the UK.
Led by James Heathers, a science integrity consultant, the team's plan is to build software tools, chase down leads from anonymous whistleblowers, and pay peer reviewers to check their work. They're aiming to identify at least 10 flawed meta-analyses a year.
The team is picking its moment wisely. As Gizmodo previously reported, AI-generated junk science is flooding the academic digital ecosystem, showing up in everything from conference proceedings to peer-reviewed journals. A study published in Harvard Kennedy School's Misinformation Review found that two-thirds of sampled papers retrieved through Google Scholar contained signs of GPT-generated text—some even in mainstream scientific outlets. About 14.5% of those bogus studies focused on health.
That's particularly alarming because Google Scholar doesn't distinguish between peer-reviewed studies and preprints, student papers, or other less-rigorous work. And once this kind of bycatch gets pulled into meta-analyses or cited by clinicians, it's hard to untangle the consequences. 'If we cannot trust that the research we read is genuine,' one researcher told Gizmodo, 'we risk making decisions based on incorrect information.'
We've already seen how nonsense can slip through. In 2021, Springer Nature retracted over 40 papers from its Arabian Journal of Geosciences—studies so incoherent they read like AI-generated Mad Libs. Just last year, the publisher Frontiers had to pull a paper featuring anatomically impossible AI-generated images of rat genitals.
We've entered the era of digital fossils, in which AI models trained on web-scraped data are beginning to preserve and propagate nonsense phrases as if they were real scientific terms. For example, earlier this year a group of researchers found a garbled set of words from a 1959 biology paper embedded in the outputs of large language models including OpenAI's GPT-4o.
In that climate, the Medical Evidence Project's goal feels more like triage than cleanup. The team is dealing with a deluge of flawed information, hiding in plain sight, and plenty of which can have very real health consequences if taken at face value.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Californian tests positive for plague after camping in Lake Tahoe area
Californian tests positive for plague after camping in Lake Tahoe area

Yahoo

time24 minutes ago

  • Yahoo

Californian tests positive for plague after camping in Lake Tahoe area

A California resident tested positive for plague, health officials said. 'The individual is currently under the care of a medical professional and is recovering at home,' El Dorado County officials said in a news release. 'It's believed that the person may have been bitten by an infected flea while camping in South Lake Tahoe area. Health officials are investigating the situation.' The county said it had notified the California Department of Public Health about the case. No other information about the person or their condition was released. Plague is caused by bacteria from bites from fleas that picked up the bacteria from a rodent. However, household pets can bring plague-infected fleas into homes. Human cases of plague are very rare, but can be very serious. Symptoms usually appear following exposure to an infected animal or flea and can include fever, nausea, weakness, swollen lymph nodes or worse. A person in northern Arizona died last month from the plague. At least 15 people have died from plague since 2000, Centers for Disease Control and Prevention data show. However, the disease can be treated effectively with antibiotics if it's diagnosed early. 'Plague is naturally present in many parts of California, including higher elevation areas of El Dorado County,' Kyle Fliflet, El Dorado County's acting director of public health, said in the news release. 'It's important that individuals take precautions for themselves and their pets when outdoors, especially while walking, hiking and or camping in areas where wild rodents are present.' _____

They Kindled Froggy Romance and Rescued Eggs to Save a Species in Mississippi
They Kindled Froggy Romance and Rescued Eggs to Save a Species in Mississippi

New York Times

time27 minutes ago

  • New York Times

They Kindled Froggy Romance and Rescued Eggs to Save a Species in Mississippi

It didn't look good for the dusky gopher frog. By the early 2000s, scientists knew of fewer than 100 adults left at a single seasonal pond in southern Mississippi, and that population faced an imminent threat: The water kept drying up before the tadpoles turned into frogs, killing them. Then, to make things worse, a parasite hit. A few survivors were taken into captivity. They refused to mate. But two decades later, the frog's trajectory has turned around. While the species remains critically endangered and still relies on intensive interventions, its numbers have grown to around 600 adults, spread out over some 15 ponds and a handful of captive populations that now produce offspring. It's been a roller-coaster ride. Over the years, collaborators — from federal and state agencies, academia, zoos and other conservation organizations — have lived through crushing lows, dizzying highs and chronic worry over the three-inch frogs. There have been brushes with disaster, like when critical genetic diversity was saved by relocating two frogs at a crucial moment. There have been quixotic quests to kindle froggy romance: Entire ponds have been constructed at the Memphis Zoo to tempt captive populations into mating. 50 States, 50 Fixes is a series about local solutions to environmental problems. More to come this year. Not to mention the mundane logistics. Some of the most important work has to happen on frog time (at night) and in frog weather (pouring rain). A pond where the frogs have been released into the wild. Tony Cenicola/The New York Times A froglet going through metamorphosis. Tony Cenicola/The New York Times Frogs being released into the wild. Whitney Steinfeld/Memphis Zoo An adult frog. A pond built at the Memphis Zoo. Zoo frogs in an imitation burrow. Tony Cenicola/The New York Times Glen's Pond, named for the researcher who discovered dusky gopher frogs there. John Tupy, USFWS A tortoise in its burrow, which the frogs also like to use. Tony Cenicola/The New York Times Sinlan Poo at a pond where frogs are reintroduced to nature. Tony Cenicola/The New York Times Want all of The Times? Subscribe.

Surf Bio Announces Peer-Reviewed Publication Demonstrating Feasibility of Subcutaneous Delivery of Ultra-Concentrated Biologics
Surf Bio Announces Peer-Reviewed Publication Demonstrating Feasibility of Subcutaneous Delivery of Ultra-Concentrated Biologics

Yahoo

time27 minutes ago

  • Yahoo

Surf Bio Announces Peer-Reviewed Publication Demonstrating Feasibility of Subcutaneous Delivery of Ultra-Concentrated Biologics

Research conducted by Stanford University and published in Science Translational Medicine shows successful injection of protein formulations exceeding 500 mg/mL PALO ALTO, Calif., Aug. 20, 2025 /PRNewswire/ -- Surf Bio, a biopharmaceutical company transforming the delivery of antibodies and biologics, announced today that a peer-reviewed study conducted by researchers at Stanford University and published in Science Translational Medicine has demonstrated the feasibility of reformulating biologics for subcutaneous delivery at ultra-high concentrations. The study's lead author, Carolyn Jons, Ph.D., and collaborators reported that spray-dried microparticle formulations surpassed 500 mg/mL and were delivered through a standard 27-gauge needle at clinically relevant forces, marking a potential breakthrough in expanding access to infusion-only therapies. The paper, entitled, "Glassy Surfactants Enable Ultra-High Concentration Biologic Therapeutics," may be accessed via the following URL: "The research addresses one of the most persistent challenges in drug delivery: how to administer high-dose biologic therapies without the need for intravenous infusion," stated Dr. Jons. "Many existing protein-based therapies require hospital or clinic-based infusions due to their large volume, instability, or reconstitution requirements. This study describes a spray-drying process that converts protein formulations into microparticles suspended in a non-solvent liquid carrier, resulting in a stable, ready-to-inject solution that meets the viscosity and force thresholds for subcutaneous administration." "This research provides a critical foundation for our work at Surf Bio and highlights the significant potential of our SnapShot™ technology," said Bryan Mazlish, CEO of Surf Bio. "We're leveraging this licensed platform to help unlock subcutaneous administration for therapies that have historically required IV infusion. Our goal is to translate this innovation into ready-to-inject, patient-friendly formulations that reduce burden on the healthcare system while enabling self-administration at home." Importantly, the platform utilizes a polymer excipient that improves stability during spray drying and enhances the injectability of the final formulation. In preclinical models, these microparticles were shown to maintain protein activity and structure, achieving doses well beyond those currently accessible with drug products approved for subcutaneous delivery. The technology does not require any specialized delivery device and can be used with commercially available autoinjectors and standard fill-finish processes. About Surf Bio:Surf Bio is a biopharmaceutical company transforming the delivery of antibodies and biologics via its SnapShot™ technology platform. Powered by the Company's proprietary polymer, SnapShot enables the development of ultra-high concentration formulations of monoclonal antibodies (mAbs) and biologics that can be administered using a single, standard autoinjector shot. To date, in-vitro and in-vivo safety and efficacy data have demonstrated that SnapShot enables drug developers to produce very high concentration, subcutaneous formulations of novel mAbs and biologics. Surf Bio was launched by the founders of Bigfoot Biomedical and AGC to commercialize a breakthrough drug delivery technology developed in the Appel lab at Stanford University. For more information about Surf Bio, visit Contact for Surf Bio:Tiberend Strategic Advisors, Reissereiss@ View original content to download multimedia: SOURCE Surf Bio, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store